Indian TB cases highlight need for drug-resistance tests

A renewed call for cheap tests that can rapidly identify resistant forms of the disease.

Read More →

South Africa: Health Barometer shows slight progress

According to the District Health Barometer, TB and HIV are still the main causes of death. But the Barometer reveals that some districts have shown great improvements in tackling these diseases.

Read More →

More than 900 000 lives saved by protecting people living with HIV from TB

Updated WHO guidance launched today scales up effective public health interventions to reduce TB deaths for people living with HIV.

Read More →

A court case and a mathematical model expose the risk of TB in South African prisons

Dudley Lee's case reveals how overcrowding and a struggling court system are fuelling a TB epidemic.

Read More →

Strong advocacy needed to eliminate TB as a major killer of children

A new paper outlining the pressing need for more advocacy efforts to address childhood TB has been published in the European Respiratory Journal.

Read More →

European Medicines Agency recommends first-line anti-TB drugs for children

The European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) agrees with the World Health Organization (WHO) dosing recommendations for ethambutol, isoniazid, pyrazinamide, and rifampicin as first-line antituberculosis medicines used in children, according to new EMA dosing guidelines released February 17.

Read More →

Review: Tuberculosis and HIV co-infection

TB/HIV co-infection represents a novel pathogenic scenario at the global level. Our knowledge about the mechanisms of interaction of the two pathogens still has many gaps that need to be filled in order to develop preventive measures against the two diseases.

Read More →

Obama’s global, domestic & HIV research FY 2013 budget backslides on existing commitments

Treatment Action Group (TAG) is deeply disappointed by President Obama’s proposed cuts to PEPFAR (President’s Emergency Plan for AIDS Relief) and bilateral TB funds, freezing of NIH (National Institutes of Health) research as well as the insufficient attention to the worsening domestic AIDS crisis in the administration's fiscal year 2013 budget plan.

Read More →

Getting to zero – elements of a TB elimination campaign for leaders to endorse and implement

We need a new vision for TB writes AIDS and TB activist Mark Harrington, Executive Director of the Treatment Action Group.

Read More →

Need for expanded access to two promising MDR TB drugs

Two experimental drugs for the treatment of MDR TB have completed phase II clinical trials.

Read More →

Page 81 of 86 · Total posts: 10

←First 80 81 82 Last→

To subscribe to the Weekly Newsletter of new posts, enter your email here:

Learn About TB